The DOI matches its Crossref record; 358 of the 358 references it cites were found in a registry or an index.
Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities
Open accessAbstract
The tumor microenvironment is proposed to contribute substantially to the progression of cancers, including breast cancer. Cancer‐associated fibroblasts (CAFs) are the most abundant components of the tumor microenvironment. Studies have revealed that CAFs in breast cancer originate from several types of cells and promote breast cancer malignancy by secreting factors, generating exosomes, releasing nutrients, reshaping the extracellular matrix, and suppressing the function of immune cells. CAFs are also becoming therapeutic targets for breast cancer due to their specific distribution in tumors and their unique biomarkers. Agents interrupting the effect of CAFs on surrounding cells have been developed and applied in clinical trials. Here, we reviewed studies examining the heterogeneity of CAFs in breast cancer and expression patterns of CAF markers in different subtypes of breast cancer. We hope that summarizing CAF‐related studies from a historical perspective will help to accelerate the development of CAF‐targeted therapeutic strategies for breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–358 of 358
Duperret, E. K., Trautz, A., Ammons, D. T., Perales‐Puchalt, A., Wise, M. C., Yan, J., Reed, C., & Weiner, D. B. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2033 · Cited by 162
Cancer associated fibroblast FAK regulates malignant cell metabolism
Demircioglu, F., Wang, J., Candido, J. B., Costa, A. S. H., Casado, P., de Luxán‐Delgado, B., Reynolds, L. E., Gómez-Escudero, J., Newport, E., Rajeeve, V., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15104-3 · Cited by 162
Giussani, M., Merlino, G., Cappelletti, V., Tagliabue, E., & Daidone, M. G. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.09.012 · Cited by 161
Saadi, A., Shannon, N. B., Lao-Sirieix, P., O’Donovan, M., Walker, E., Clemons, N. J., Hardwick, J. S., Zhang, C., Das, M., Save, V., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909797107 · Cited by 161
Chan, T.-S., Hsu, C.-C., Pai, V. C., Liao, W.-Y., Huang, S.-S., Tan, K.-T., Yen, C.-J., Hsu, S.-C., Chen, W.-Y., Shan, Y.-S., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151665 · Cited by 161
Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression
Ren, J., Smid, M., Iaria, J., Salvatori, D. C. F., van Dam, H., Zhu, H. J., Martens, J. W. M., & ten Dijke, P. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1194-0 · Cited by 160
TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype
Fessler, E., Drost, J., van Hooff, S. R., Linnekamp, J. F., Wang, X., Jansen, M., De Sousa E Melo, F., Prasetyanti, P. R., IJspeert, J. E., Franitza, M., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606184 · Cited by 159
Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming
Mishra, R., Haldar, S., Placencio, V., Madhav, A., Rohena-Rivera, K., Agarwal, P., Duong, F., Angara, B., Tripathi, M., Liu, Z., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99397 · Cited by 159
de Sostoa, J., Fajardo, C. A., Moreno, R., Ramos, M. D. B., Farrera-Sal, M., & Alemany, R. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0505-4 · Cited by 159
Impact of Epithelial–Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ
Strell, C., Paulsson, J., Jin, S.-B., Tobin, N. P., Mezheyeuski, A., Roswall, P., Mutgan, C., Mitsios, N., Johansson, H., Wickberg, S. M., et al. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy234 · Cited by 158
Martinez‐Outschoorn, U., Whitaker‐Menezes, D., Pavlides, S., Chiavarina, B., Bonuccelli, G., Trimmer, C., Tsirigos, A., Migneco, G., Witkiewicz, A. K., Balliet, R. M., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.21.13817 · Cited by 158
Roswall, P., Bocci, M., Bartoschek, M., Li, H., Kristiansen, G., Jansson, S., Lehn, S., Sjölund, J., Reid, S., Larsson, C., et al. (2018) · Nature Medicine · doi:10.1038/nm.4494 · Cited by 156
Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer
Ngan, C. Y., Yamamoto, H., Seshimo, I., Tsujino, T., Man-i, M., Ikeda, J.-I., Konishi, K., Takemasa, I., Ikeda, M., Sekimoto, M., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603651 · Cited by 155
Differential effects of gamma-interferon on collagen and fibronectin gene expression.
Czaja, M. J., Weiner, F. R., Eghbali, M., Giambrone, M. A., Eghbali, M., & Zern, M. Α. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45207-6 · Cited by 152
Mercier, I., Casimiro, M. C., Wang, C., Rosenberg, A., Quong, J. N., Minkeu, A., Allen, K. G., Danilo, C., Sotgia, F., Bonuccelli, G., et al. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.8.6220 · Cited by 151
Yu, T., Yang, G., Hou, Y., Tang, X., Wu, C., Wu, X.-A., Guo, L., Zhu, Q., Luo, H., Du, Y.-E., et al. (2016) · Oncogene · doi:10.1038/onc.2016.370 · Cited by 151
Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis
Singh, R., Gupta, S. C., Peng, W.-X., Zhou, N., Pochampally, R. R., Atfi, A., Watabe, K., Lü, Z., & Mo, Y.-Y. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.168 · Cited by 150
Gao, Y., Li, X., Zeng, C., Liu, C., Hao, Q., Li, W., Zhang, K., Zhang, W., Wang, S., Zhao, H., et al. (2020) · Advanced Science · doi:10.1002/advs.202002518 · Cited by 150
Truong, D. D., Kratz, A., Park, J. G., Barrientos, E. S., Saini, H., Nguyen, T., Pockaj, B., Mouneimne, G., LaBaer, J., & Nikkhah, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2293 · Cited by 149
Neural Crest and Tooth Morphogenesis
Sharpe, P. T. (2001) · Advances in Dental Research · doi:10.1177/08959374010150011001 · Cited by 149
Vu, L. T., Peng, B., Zhang, D. X., Ma, V. W. S., Mathey-Andrews, C. A., Lam, C. K., Kiomourtzis, T., Jin, J., McReynolds, L. A., Huang, L., et al. (2019) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2019.1599680 · Cited by 147
The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis
Têtu, B., Brisson, J., Wang, C. S., Lapointe, H., Beaudry, G., Blanchette, C., & Trudel, D. (2006) · Breast Cancer Research · doi:10.1186/bcr1503 · Cited by 146
Physico-mechanical aspects of extracellular matrix influences on tumorigenic behaviors
Cukierman, E., & Bassi, D. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.04.004 · Cited by 146
Wan, X., Guan, S., Hou, Y., Qin, Y., Zeng, H., Yang, L., Qiao, Y., Liu, S., Li, Q., Jin, T., et al. (2021) · Theranostics · doi:10.7150/thno.55074 · Cited by 146
Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways
Romon, R., Adriaenssens, É., Lagadec, C. H., Germain, E., Hondermarck, H., & Bourhis, X. L. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-157 · Cited by 144
Molecular Repair, Wound Healing, And Carcinogenesis: Tumor Production A Possible Overhealing?
Haddow, A. (1973) · Advances in cancer research · doi:10.1016/s0065-230x(08)60341-3 · Cited by 143
Matrix stiffness regulates migration of human lung fibroblasts
Asano, S., Ito, S., Takahashi, K., Furuya, K., Kondo, M., Sokabe, M., & Hasegawa, Y. (2017) · Physiological Reports · doi:10.14814/phy2.13281 · Cited by 143
Nerve growth factor overexpression and autocrine loop in breast cancer cells
Dollé, L., Yazidi‐Belkoura, I. E., Adriaenssens, É., Nurcombe, V., & Hondermarck, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206805 · Cited by 142
Balanis, N. G., Wendt, M. K., Schiemann, B. J., Wang, Z., Schiemann, W. P., & Carlin, C. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.475277 · Cited by 141
Li, Y., Zhao, Z., Liu, W., & Li, X. (2020) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-020-03244-7 · Cited by 140
Ariga, N., Sato, E., Ohuchi, N., Nagura, H., & Ohtani, H. (2001) · International Journal of Cancer · Cited by 139
Sansone, P., Berishaj, M., Rajasekhar, V. K., Ceccarelli, C., Chang, Q., Strillacci, A., Savini, C., Shapiro, L., Bowman, R. L., Mastroleo, C., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2129 · Cited by 139
Sun, K., Tang, S., Hou, Y., Xi, L., Chen, Y., Yin, J., Peng, M., Zhao, M., Cui, X., & Liu, M. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.02.025 · Cited by 138
miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling
Helou, R. E., Pinna, G., Cabaud, O., Wicinski, J., Bhajun, R., Guyon, L., Rioualen, C., Finetti, P., Gros, A., Mari, B. P., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.016 · Cited by 136
Soon, P. S. H., Kim, E., Pon, C. K., Gill, A. J., Moore, K., Spillane, A. J., Benn, D. E., & Baxter, R. C. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0227 · Cited by 134
Marusyk, A., Tabassum, D. P., Janiszewska, M., Place, A. E., Trinh, A. C., Rozhok, A. I., Pyne, S., Guerriero, J. L., Shu, S., Ekram, M. B., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1457 · Cited by 130
Xi, L., Peng, M., Liu, S., Liu, Y., Wan, X., Hou, Y., Qin, Y., Yang, L., Chen, S.-C., Zeng, H., et al. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12146 · Cited by 130
A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice
Fang, J., Liang, X., Joo, K., Liu, Y., Zhang, C., Liu, S., Conti, P. S., Li, Z., & Wang, P. (2015) · International Journal of Cancer · doi:10.1002/ijc.29831 · Cited by 129
Self-citationCancer-associated fibroblasts support vascular growth through mechanical force
Sewell-Loftin, M. K., Bayer, S. V. H., Crist, E., Hughes, T., Joison, S. M., Longmore, G. D., & George, S. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-13006-x · Cited by 128
Prognostic Impact of Cancer-Associated Stromal Cells in Patients With Stage I Lung Adenocarcinoma
Ito, M., Ishii, G., Nagai, K., Maeda, R., Nakano, Y., & Ochiai, A. (2012) · CHEST Journal · doi:10.1378/chest.11-2458 · Cited by 124
Chen, Y., Zeng, C., Zhan, Y., Wang, H., Jiang, X., & Li, W. (2017) · Oncogene · doi:10.1038/onc.2017.100 · Cited by 123
Zhou, Z., Zhou, Q., Wu, X., Xu, S., Hu, X., Tao, X., Li, B., Peng, J., Li, D., Shen, L., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.12.039 · Cited by 123
Nakano, M., Kikushige, Y., Miyawaki, K., Kunisaki, Y., Mizuno, S., Takenaka, K., Tamura, S., Okumura, Y., Ito, M., Ariyama, H., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0480-0 · Cited by 122
Nakanishi, Y., Akiyama, N., Tsukaguchi, T., Fujii, T., Sakata, K., Sase, H., Isobe, T., Morikami, K., Shindoh, H., Mio, T., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0248 · Cited by 121
Li, C., Yang, D., Cao, X., Wang, F., Hong, D.-Y., Wang, J., Shen, X., & Chen, Y. (2017) · Oncology Letters · doi:10.3892/ol.2017.5896 · Cited by 119
MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer
Zhao, L., Sun, Y., Hou, Y., Peng, Q., Wang, L., Luo, H., Tang, X., Zeng, Z., & Liu, M. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.08.005 · Cited by 118
Self-citationCancer-Associated Fibroblasts Produce Netrin-1 to Control Cancer Cell Plasticity
Sung, P., Rama, N., Imbach, J., Fiore, S., Ducarouge, B., Neves, D., Chen, H., Bernard, D., Yang, P., Bernet, A., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2952 · Cited by 118
Amornsupak, K., Insawang, T., Thuwajit, P., O‐charoenrat, P., Eccles, S. A., & Thuwajit, C. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-955 · Cited by 117
Huang, M., Li, Y., Zhang, H., & Nan, F. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-80 · Cited by 116
Arandkar, S., Furth, N., Elisha, Y., Nataraj, N. B., van der Kuip, H., Yarden, Y., Aulitzky, W. E., Ulitsky, I., Geiger, B., & Oren, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719076115 · Cited by 116
Peiris-Pagès, M., Sotgia, F., & Lisanti, M. P. (2015) · Oncotarget · doi:10.18632/oncotarget.3828 · Cited by 115
LncRNA AK023948 is a positive regulator of AKT
Koirala, P., Huang, J., Ho, T.-T., Wu, F., Ding, X., & Mo, Y. (2017) · Nature Communications · doi:10.1038/ncomms14422 · Cited by 114
Neurotrophins and their receptors in breast cancer
Hondermarck, H. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.06.004 · Cited by 113
Salem, A. F., Whitaker‐Menezes, D., Zhao, L., Martinez‐Outschoorn, U., Tanowitz, H. B., Zoubi, M. S. A., Howell, A., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2012) · Cell Cycle · doi:10.4161/cc.20920 · Cited by 113
Hannafon, B. N., Cai, A., Calloway, C. L., Xu, Y., Zhang, R., Fung, K., & Ding, W. (2019) · BMC Cancer · doi:10.1186/s12885-019-5839-2 · Cited by 110
Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles
Tchou, J. C., Kossenkov, A. V., Chang, L., Satija, C., Herlyn, M., Showe, L. C., & Puré, E. (2012) · BMC Medical Genomics · doi:10.1186/1755-8794-5-39 · Cited by 108
Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression
Sha, S., Yuan, D., Liu, Y., Han, B., Zhong, N., & Liu, Z. (2017) · Biology Open · doi:10.1242/bio.023135 · Cited by 108
Saad, S., Gottlieb, D. J., Bradstock, K. F., Overall, C. M., & Bendall, L. J. (2002) · PubMed · Cited by 107
Cancer-Associated Fibroblasts as Targets for Immunotherapy
Kakarla, S., Song, X., & Gottschalk, S. M. (2012) · Immunotherapy · doi:10.2217/imt.12.112 · Cited by 106
Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation
Fernández‐Nogueira, P., Mancino, M., Fuster, G., López‐Plana, A., Jáuregui, P., Almendro, V., Enreig, E., Menéndez, S., Rojo, F., Noguera‐Castells, A., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0353 · Cited by 106
Deying, W., Feng, G., Shumei, L., Zhao, H., Liu, M., & Hongqing, W. (2017) · Bioscience Reports · doi:10.1042/bsr20160470 · Cited by 105
Jin, Z., Lu, Y., Wu, X., Pan, T., Yu, Z., Hou, J., Wu, A., Li, J., Yang, Z., Li, C., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102076 · Cited by 104
Simpkins, S. A., Hanby, A. M., Holliday, D. L., & Speirs, V. (2012) · The Journal of Pathology · doi:10.1002/path.4034 · Cited by 103
SCHOPPMANN, S. F., Berghoff, A. S., Dinhof, C., Jakesz, R., Gnant, M., Dubsky, P. C., Jesch, B., Heinzl, H., & Birner, P. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1984-x · Cited by 103
Osuala, K. O., Sameni, M., Shah, S., Aggarwal, N., Simonait, M. L., Franco, O. E., Hong, Y., Hayward, S. W., Behbod, F., Mattingly, R. R., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1576-3 · Cited by 103
Coulson, R. S., Liew, S. H., Connelly, A. A., Yee, N. S., Deb, S., Kumar, B., Vargas, A. C., O'Toole, S. A., Parslow, A. C., Poh, A. R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15553 · Cited by 103
Puła, B., Jethon, A., Piotrowska, A., Gomułkiewicz, A., Owczarek, T. B., Calik, J., Wojnar, A., Witkiewicz, W., Ryś, J., Ugorski, M., et al. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.04060.x · Cited by 102
Cancer-associated fibroblasts promote the stemness of CD24+ liver cells via paracrine signaling
Li, Y., Wang, R., Xiong, S., Wang, X., Zhao, Z., Bai, S., Wang, Y., Zhao, Y., & Cheng, B. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1731-9 · Cited by 100
PDGF Receptors in Tumor Biology: Prognostic and Predictive Potential
Paulsson, J., Ehnman, M., & Östman, A. (2014) · Future Oncology · doi:10.2217/fon.14.83 · Cited by 99
Hussain, A., Voisin, V., Poon, S., Karamboulas, C., Bui, N. H. B., Meens, J., Dmytryshyn, J., Ho, V. W., Tang, K. H., Paterson, J., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191094 · Cited by 99
Surowiak, P., Murawa, D., Materna, V., Maciejczyk, A., Pudełko, M., Cieśla, S., Bręborowicz, J., Murawa, P., Zabel, M., Dietel, M., et al. (2007) · PubMed · Cited by 95
Impact of matrix stiffness on fibroblast function
El-Mohri, H., Wu, Y. B., Mohanty, S., & Ghosh, G. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.02.001 · Cited by 95
Therapeutic Potentials of BDNF/TrkB in Breast Cancer; Current Status and Perspectives
Tajbakhsh, A., Mokhtari‐Zaer, A., Rezaee, M., Afzaljavan, F., Rivandi, M., Hassanian, S. M., Ferns, G. A., Pasdar, A., & Avan, A. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25943 · Cited by 94
Peng, Q., Zhao, L., Hou, Y., Sun, Y., Wang, L., Luo, H., Peng, H., & Liu, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060321 · Cited by 93
Self-citationLi, K., Liu, T., Chen, J., Ni, H., & Li, W. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013805 · Cited by 93
Inhibition of Breast Cancer Metastases by a Novel Inhibitor of TGFβ Receptor 1
Fang, Y., Chen, Y., Yu, L., Zheng, C., Ya, Q., Li, Z., Yang, Z., Zhang, Y., Shi, T., Luo, J., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs485 · Cited by 92
Self-citationMulsow, J., Watson, R. W. G., Fitzpatrick, J. M., & O’Connell, P. R. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000189606.58343.cd · Cited by 91
Li, A., Chen, P., Leng, Y., & Kang, J. (2018) · Oncogene · doi:10.1038/s41388-018-0379-9 · Cited by 91
From Warburg effect to Reverse Warburg effect; the new horizons of anti-cancer therapy
Benny, S., Mishra, R., Kumar, M. K. M., & Aneesh, T. P. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110216 · Cited by 91
Haubeiß, S., Schmid, J. O., Mürdter, T. E., Sonnenberg, M., Friedel, G., van der Kuip, H., & Aulitzky, W. E. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-168 · Cited by 90
Park, S. Y., Kim, H. M., & Koo, J. S. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3291-9 · Cited by 84
Qian, X., Pan, Y., Huang, Q.-Y., Shi, Y., Huang, Q.-Y., Hu, Z., & Xiong, L. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s191317 · Cited by 84
Self-citationSchulte, J., Weidig, M., Balzer, P., Richter, P., Franz, M., Junker, K., Gajda, M. R., Friedrich, K., Wunderlich, H., Östman, A., et al. (2012) · Histochemistry and Cell Biology · doi:10.1007/s00418-012-0998-0 · Cited by 83
Zhang, J., Chen, L., Liu, X., Kammertoens, T., Blankenstein, T. J. F., & Qin, Z. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3022 · Cited by 83
Self-citationWang, W.-Q., Liu, L., Xu, H., Luo, G., Chen, T., Wu, C., Xu, Y.-F., Xu, J., Liu, C., Zhang, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071189 · Cited by 83
Infante, J. R., Korn, R. L., Rosen, L. S., LoRusso, P., Dychter, S. S., Zhu, J., Maneval, D. C., Jiang, P., Shepard, H. M., Frost, G., et al. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.327 · Cited by 83
Butti, R., Nimma, R., Kundu, G., Bulbule, A., Kumar, T. V. S., Gunasekaran, V. P., Kumar, D., Kumar, D., Mane, A., Gill, S. S., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01663-2 · Cited by 83
Jahangiri, B., Khalaj‐Kondori, M., Asadollahi, E., & Sadeghizadeh, M. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-0471-5 · Cited by 82
Non-coding RNAs as potential therapeutic targets in breast cancer
Tomar, D., Yadav, A. S., Kumar, D., Bhadauriya, G., & Kundu, G. C. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.04.005 · Cited by 82
A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer
Bonneau, C., Eliès, A., Kieffer, Y., Bourachot, B., Ladoire, S., Pelon, F., Héquet, D., Guinebretière, J. M., Blanchet, C., Vincent‐Salomon, A., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01311-9 · Cited by 81
Louault, K., Bonneaud, T. L., Séveno, C., Gomez‐Bougie, P., Nguyen, F., Gautier, F., Bourgeois, N., Loussouarn, D., Kerdraon, O., Barillé‐Nion, S., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0635-z · Cited by 80
Yan, Z., Sheng, Z., Zheng, Y., Feng, R., Xiao, Q., Shi, L., Li, H., Yin, C., Luo, H., Hao, C., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04409-w · Cited by 80
Suh, J., Kim, D., Lee, Y., Jang, J., & Surh, Y. (2020) · Molecular Carcinogenesis · doi:10.1002/mc.23233 · Cited by 79
Park, C. K., Jung, W. H., & Koo, J. S. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3929-2 · Cited by 77
Clift, R., Souratha, J., Garrovillo, S. A., Zimmerman, S. J., & Blouw, B. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3060 · Cited by 77
The androgen receptor/filamin A complex as a target in prostate cancer microenvironment
Donato, M. D., Zamagni, A., Galasso, G., Zazzo, E. D., Giovannelli, P., Barone, M. V., Zanoni, M., Gunelli, R., Costantini, M., Auricchio, F., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03402-7 · Cited by 77
Li, Y., & Disney, M. D. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00827 · Cited by 75
A Subset of Cancer-Associated Fibroblasts Determines Therapy Resistance
Huelsken, J., & Hanahan, D. (2018) · Cell · doi:10.1016/j.cell.2018.01.028 · Cited by 72
Tomellini, E., Touil, Y. S., Lagadec, C. H., Julien, S., Ostyn, P., Gelus, N., Meignan, S., Lengrand, J., Adriaenssens, É., Polakowska, R. R., et al. (2014) · Stem Cells · doi:10.1002/stem.1849 · Cited by 69
Liu, Y., Zhang, J., Sun, X., Su, Q., & You, C. (2017) · Oncotarget · doi:10.18632/oncotarget.17136 · Cited by 69
The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis
Xu, K., Tian, X., Oh, S. Y., Movassaghi, M., Naber, S. P., Kuperwasser, C., & Buchsbaum, R. J. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0674-8 · Cited by 68
Prognostic Significance in Breast Cancer of a Gene Signature Capturing Stromal PDGF Signaling
Frings, O., Augsten, M., Tobin, N. P., Carlson, J. W., Paulsson, J., Peña, C., Olsson, E., Veerla, S., Bergh, J. C. S., Östman, A., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.02.018 · Cited by 67
Kim, H. M., Jung, W. H., & Koo, J. S. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0587-9 · Cited by 66
Li, H., Zhang, J., Chen, S., Liu, L.-L., Li, L., Gao, F., Zhuang, S.-M., Wang, L.-P., Li, Y., & Song, M. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0551-8 · Cited by 66
Self-citationShah, S. H., Miller, P., García-Contreras, M., Ao, Z., Machlin, L., Issa, E., & El‐Ashry, D. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1071742 · Cited by 65
Choi, S., Sung, R., Lee, S.-J., Lee, T., Kim, N., Yoon, S. M., Lee, E. J., Chae, H. B., Youn, S. J., & Park, S. M. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.9.1293 · Cited by 65
Aoto, K., Ito, K., & Aoki, S. (2018) · Oncotarget · doi:10.18632/oncotarget.26124 · Cited by 65
Chatterjee, A., Jana, S., Chatterjee, S., Wastall, L. M., Mandal, G., Nargis, N., Roy, H., Hughes, T. A., & Bhattacharyya, A. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0566-7 · Cited by 64
Yan, L., Wang, P., Fang, W., & Liang, C. (2019) · Cell Biochemistry and Function · doi:10.1002/cbf.3462 · Cited by 64
Ono, S., Ishii, G., Nagai, K., Takuwa, T., Yoshida, J., Nishimura, M., Hishida, T., Aokage, K., Fujii, S., Ikeda, N., et al. (2013) · CHEST Journal · doi:10.1378/chest.12-0913 · Cited by 63
Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis
Jungwirth, U., van Weverwijk, A., Evans, R. J., Jenkins, L., Vicente, D., Alexander, J. J., Gao, Q., Haider, S. A., Iravani, M., & Isacke, C. M. (2021) · Nature Communications · doi:10.1038/s41467-021-23583-1 · Cited by 63
Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancer
Femel, J., Huijbers, E. J. M., Saupe, F., Cedervall, J., Zhang, L., Roswall, P., Larsson, E., Olofsson, H., Pietras, K., Dimberg, A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2628 · Cited by 62
Gottschalk, S. M., Feng, Y., Ji, M., Kakarla, S., & Song, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082658 · Cited by 61
Park, C., Min, K. N., Son, J., Park, S.-Y., Nam, J., Kim, D., & Sheen, Y. Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.05.006 · Cited by 59
Choi, Y. P., Lee, J. H., Gao, M., Kim, B. G., Kang, S., Kim, S. H., & Cho, N. H. (2014) · International Journal of Cancer · doi:10.1002/ijc.28848 · Cited by 55
Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein (M7824)
Jochéms, C., Tritsch, S. R., Pellom, S. T., Su, Z., Soon‐Shiong, P., Wong, H. C., Gulley, J. L., & Schlom, J. (2017) · Oncotarget · doi:10.18632/oncotarget.20680 · Cited by 55
Hong, H., Zhou, T., Fang, S., Jia, M., Xu, Z., Dai, Z., Li, C., Li, S., Li, L., Zhang, T., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3154-9 · Cited by 53
Tsai, Y., Tseng, L., Hsu, C., Yang, M., Chiu, J., & Shyr, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178173 · Cited by 53
Yi, Y., Wu, M., Zeng, H., Hu, W., Zhao, C., Xiong, M., Lv, W., Deng, P., Zhang, Q., & Wu, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.738945 · Cited by 53
Mobarra, N., Shafiee, A., Rad, S. M. A. H., Tasharrofi, N., Zomorrod, M. S., Hafizi, M., Movahed, M., Kouhkan, F., & Soleimani, M. (2015) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-015-9872-4 · Cited by 52
Shen, Z., Qin, X., Yan, M., Li, R., Chen, G., Zhang, J., & Chen, W. (2016) · Oncotarget · doi:10.18632/oncotarget.13609 · Cited by 52
GPER in CAFs regulates hypoxia-driven breast cancer invasion in a CTGF-dependent manner
Ren, J., Guo, H., Wu, H., Tian, T., Dong, D., Zhang, Y., Sui, Y.-X., Zhang, Y., Zhao, D., Wang, S., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.3779 · Cited by 50
Self-citationPIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression
Gagliano, T., Shah, K., Gargani, S., Lao, L., Alsaleem, M. A., Chen, J., Ntafis, V., Huang, P., Ditsiou, A., Vella, V., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci128313 · Cited by 50
Role of secreted type I collagen derived from stromal cells in two breast cancer cell lines
Kim, S. H., Lee, H. Y., Jung, S. P., Kim, S., Lee, J. E., Nam, S. J., & Bae, J. W. (2014) · Oncology Letters · doi:10.3892/ol.2014.2199 · Cited by 49
Chakravarthy, R., Mnich, K., & Gorman, A. M. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.149 · Cited by 49
Liu, Y., Yang, Y., Du, J.-X., Lin, D., & Li, F. (2020) · IUBMB Life · doi:10.1002/iub.2292 · Cited by 49
Suchański, J., Tejchman, A., Zacharski, M., Piotrowska, A., Grzegrzółka, J., Chodaczek, G., Nowińska, K., Ryś, J., Dzięgiel, P., Kiéda, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184970 · Cited by 48
Ren, Z.-J., Lv, M., Yu, Q., Bao, J., Lou, K., & Li, X. (2021) · The FASEB Journal · doi:10.1096/fj.202001430rr · Cited by 47
Caveolin-1 is a Modulator of Fibroblast Activation and a Potential Biomarker for Gastric Cancer
Shen, X., Zhang, H., Tang, G., Wang, X., Zheng, R., Wang, Y., Zhu, Y., Xue, X., & Bi, J. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.10666 · Cited by 46
Robertson, C. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.11.009 · Cited by 45
Boesch, M., Onder, L., Cheng, H., Novković, M., Mörbe, U., Sopper, S., Gastl, G. A., Jochum, W., Ruhstaller, T., Knauer, M., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1414129 · Cited by 45
Chatterjee, S., Bhat, V., Berdnikov, A., Liu, J., Zhang, G., Buchel, E. W., Safneck, J. R., Marshall, A. J., Murphy, L. C., Postovit, L.-M. M., et al. (2019) · iScience · doi:10.1016/j.isci.2019.07.034 · Cited by 45
High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer
Paulsson, J., Rydén, L., Strell, C., Frings, O., Tobin, N. P., Fornander, T., Bergh, J. C. S., Landberg, G., Stål, O., & Östman, A. (2016) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.56 · Cited by 43
Podoplanin-expressing cancer-associated fibroblasts inhibit small cell lung cancer growth
Takahashi, A., Ishii, G., Neri, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3371 · Cited by 40
Cui, Q., Wang, B., Li, K., Sun, H., Tao, H., Zhang, Y., & Kang, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.9092 · Cited by 40
Tao, S., Li, H., Ma, X., Ma, Y., He, J., Gao, Y., & Li, J. (2020) · Cancer Gene Therapy · doi:10.1038/s41417-020-00244-x · Cited by 40
MiR-449a suppresses cell migration and invasion by targeting PLAGL2 in breast cancer
Xu, B., Zhang, X., Wang, S., & Shi, B. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2017.12.012 · Cited by 39
Dvorak-Kornaus, K. M., Pettee, K. M., Rubinic, K. A., Su, R. C., Nestor‐Kalinoski, A. L., & Eisenmann, K. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195278 · Cited by 39
Maehira, H., Miyake, T., Iida, H., Tokuda, A., Mori, H., Yasukawa, D., Mukaisho, K., Shimizu, T., & Tani, M. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07891-x · Cited by 38
Liu, Y., Hua, F., Zhan, Y., Yang, Y., Xie, J., Cheng, Y., & Li, F. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00524-x · Cited by 38
Pan, C., Liu, P., Ma, D., Zhang, S., Ni, M., Fang, Q., & Wang, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110610 · Cited by 37
HMGB1-activated fibroblasts promote breast cancer cells metastasis via RAGE/aerobic glycolysis
Chen, Y., Cai, L., Guo, X. Q., Li, Z., Liao, X., Zhang, X., Huang, L., & He, J. (2020) · Neoplasma · doi:10.4149/neo_2020_200610n620 · Cited by 37
Self-citationTumor-Infiltrating Podoplanin+ Fibroblasts Predict Worse Outcome in Solid Tumors
Hu, G., Wang, S., Xu, F., Ding, Q., Chen, W., Zhong, K., Huang, L., & Xu, Q. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495484 · Cited by 36
Zervantonakis, I. K., Poskus, M. D., Scott, A. L., Selfors, L. M., Lin, J., Dillon, D. A. R., Pathania, S., Sorger, P. K., Mills, G. B., & Brugge, J. S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000648117 · Cited by 35
Li, C., Cao, L., Xu, C., Liu, F., Xiang, G., Liu, X., Jiao, J., & Niu, Y. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.11.010 · Cited by 33
Al-Jomah, N. A., Almohanna, F., & Aboussekhra, A. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab102 · Cited by 33
Li, H., Liu, W., Zhang, X., & Wang, Y. (2021) · Oncology Letters · doi:10.3892/ol.2021.13075 · Cited by 30
Tumor-induced Stromal STAT1 Accelerates Breast Cancer via Deregulating Tissue Homeostasis
Zellmer, V. R., Schnepp, P. M., Fracci, S. L., Tan, X., Howe, E. N., & Zhang, S. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0312 · Cited by 29
Jiffar, T., Yilmaz, T., Lee, J., Miller, Y., Feng, L., El‐Naggar, A. K., & Kupferman, M. E. (2017) · Cancer Cell & Microenvironment · doi:10.14800/ccm.1566 · Cited by 28
Hockemeyer, K., Janetopoulos, C., Terekhov, A. Y., Hofmeister, W. H., Vilgelm, A. E., Costa, L. A., Wikswo, J. P., & Richmond, A. J. (2014) · Biomicrofluidics · doi:10.1063/1.4890330 · Cited by 26
Reduced hyaluronan cross-linking induces breast cancer malignancy in a CAF-dependent manner
Zhang, G., He, Y., Liu, Y., Du, Y., Yang, C., & Gao, F. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03875-6 · Cited by 25
A novel FAPα-based Z-Gly-Pro epirubicin prodrug for improving tumor-targeting chemotherapy
Wang, J., Li, Q., Li, X., Yuan, W., Huang, S., Cai, S., & Xu, J. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.09.016 · Cited by 24
Strell, C., Tullberg, A. S., Edelmann, R. J., Akslen, L. A., Malmström, P., Fernö, M., Holmberg, E. C., Östman, A., & Karlsson, P. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06136-4 · Cited by 23
Studying primary tumor–associated fibroblast involvement in cancer metastasis in mice
Duyverman, A. M. M. J., Steller, E. J. A., Fukumura, D., Jain, R. K., & Duda, D. G. (2012) · Nature Protocols · doi:10.1038/nprot.2012.031 · Cited by 19
Park, Y., Lee, K. S., Park, S. Y., Kim, J. H., Kang, E. Y., Kim, S. W., Eom, K. Y., Js, K., & Kim, I. A. (2015) · Journal of Breast Cancer · doi:10.4048/jbc.2015.18.3.249 · Cited by 16
Lee, J. H., Kim, H. M., & Koo, J. S. (2018) · Pathobiology · doi:10.1159/000492392 · Cited by 14
Nakasone, S., Mimaki, S., Ichikawa, T., Aokage, K., Miyoshi, T., Sugano, M., Kojima, M., Fujii, S., Kuwata, T., Ochiai, A., et al. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2619-3 · Cited by 8
Yamaguchi, K., Hara, Y., Kitano, I., Hamamoto, T., Kiyomatsu, K., Yamasaki, F., Yamaguchi, R., Nakazono, T., Egashira, R., Imaizumi, T., et al. (2021) · Breast Cancer · doi:10.1007/s12282-020-01198-6 · Cited by 8
Cited by
Hachey, S. J., Hatch, C. J., Gaebler, D., Mocherla, A., Nee, K., Kessenbrock, K., & Hughes, C. C. W. (2024) · Breast Cancer Research · doi:10.1186/s13058-023-01760-y · Cited by 24
Analysis of intracellular and intercellular crosstalk from omics data
Chiodi, A., Pelucchi, P., & Mosca, E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.10.552776
Metadata
- Authors
- Hu, D., Li, Z., Zheng, B., Lin, X., Pan, Y., Gong, P., Zhuo, W., Hu, Y., Chen, C., Chen, L., Zhou, J., & Wang, L.
- Venue
- Cancer Communications
- Published
- 2022-04-28
- Volume
- 42
- Issue
- 5
- Pages
- 401-434
- ISSN
- 1000-467X (ISSN-L)
- 2523-3548
- OpenAlex
- W4225001891
- Cited by
- 286
- References
- 358
- FWCI
- 20.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.